Trials / Completed
CompletedNCT00811265
Safety Evaluation of ExAblate MRgFUS for Prostate Cancer
Safety, Compatibility and Imaging Quality of ExAblate Prostate Applicator for Prostate Cancer
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- InSightec · Industry
- Sex
- Male
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the safety, compatibility and imaging quality of the ExAblate MRgFUS system.
Detailed description
The objective of this study is to evaluate safety, compatibility and imaging quality of the ExAblate MRgFUS system for prostate cancer, under simulated use conditions. No acoustic energy will be delivered and no focused ultrasound therapy will be performed. This is an imaging only study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ExAblate MRgFUS for prostate cancer | Simulated use of ExAblate MRgFUS system |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2008-12-18
- Last updated
- 2016-03-08
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00811265. Inclusion in this directory is not an endorsement.